Pick Your Threshold: A Comparison Among Different Methods of Anaerobic Threshold Evaluation in Heart Failure Prognostic Assessment.
anaerobic threshold
cardiopulmonary exercise test
heart failure
prognosis
Journal
Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
received:
18
02
2022
revised:
15
04
2022
accepted:
04
05
2022
pubmed:
27
6
2022
medline:
10
11
2022
entrez:
26
6
2022
Statut:
ppublish
Résumé
In clinical practice, anaerobic threshold (AT) is used to guide training and rehabilitation programs, to define risk of major thoracic or abdominal surgery, and to assess prognosis in heart failure (HF). AT of oxygen uptake (V.O What is the prognostic power of these different ways to report AT? In this observational cohort study, we screened data of 7,746 patients with HF with a history of reduced ejection fraction (< 40%) recruited between 1998 and 2020 and enrolled in the Metabolic Exercise Combined With Cardiac and Kidney Indexes register. All patients underwent a maximum cardiopulmonary exercise test, executed using a ramp protocol on an electronically braked cycle ergometer. This study considered 6,157 patients with HF with identified AT. Follow-up was median, 4.2 years (25th-75th percentiles, 1.9-5.0 years). Both V.O In HF, V.O
Sections du résumé
BACKGROUND
In clinical practice, anaerobic threshold (AT) is used to guide training and rehabilitation programs, to define risk of major thoracic or abdominal surgery, and to assess prognosis in heart failure (HF). AT of oxygen uptake (V.O
RESEARCH QUESTION
What is the prognostic power of these different ways to report AT?
STUDY DESIGN AND METHODS
In this observational cohort study, we screened data of 7,746 patients with HF with a history of reduced ejection fraction (< 40%) recruited between 1998 and 2020 and enrolled in the Metabolic Exercise Combined With Cardiac and Kidney Indexes register. All patients underwent a maximum cardiopulmonary exercise test, executed using a ramp protocol on an electronically braked cycle ergometer.
RESULTS
This study considered 6,157 patients with HF with identified AT. Follow-up was median, 4.2 years (25th-75th percentiles, 1.9-5.0 years). Both V.O
INTERPRETATION
In HF, V.O
Identifiants
pubmed: 35753386
pii: S0012-3692(22)01184-9
doi: 10.1016/j.chest.2022.05.039
pii:
doi:
Types de publication
Observational Study
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1106-1115Investigateurs
Stefania Farina
(S)
Beatrice Pezzuto
(B)
Anna Apostolo
(A)
Pietro Palermo
(P)
Mauro Contini
(M)
Paola Gugliandolo
(P)
Irene Mattavelli
(I)
Michele Della Rocca
(M)
Giovanna Gallo
(G)
Federica Moscucci
(F)
Anita Iorio
(A)
Geza Halasz
(G)
Bruno Capelli
(B)
Simone Binno
(S)
Giuseppe Pacileo
(G)
Fabio Valente
(F)
Rossella Vastarella
(R)
Denise Zaffalon
(D)
Cosimo Carriere
(C)
Marco Masè
(M)
Marco Cittar
(M)
Andrea Di Lenarda
(A)
Sergio Caravita
(S)
Elena Viganò
(E)
Giovanni Marchese
(G)
Roberto Ricci
(R)
Luca Arcari
(L)
Domenico Scrutinio
(D)
Elisa Battaia
(E)
Michele Moretti
(M)
Maria Vittoria Matassini
(MV)
Matilda Shkoza
(M)
Roland Herberg
(R)
Antonio Cittadini
(A)
Andrea Salzano
(A)
Alberto Marra
(A)
Eluisa Lafranca
(E)
Giuseppe Vitale
(G)
Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.